Pharma Aids (DHA:PHARMAID) Cyclically Adjusted FCF per Share: BDT8.82 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:PHARMAID Pharma Aids Ltd DHA:PHARMAID
73 GF Score
Price BDT611.00
GF Value BDT761.21
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Pharma Aids Cyclically Adjusted FCF per Share?

Pharma Aids DHA:PHARMAID -1.78% 73 Cyclically Adjusted FCF per Share is BDT8.82 as of Mar. 2026. GuruFocus rates DHA:PHARMAID with a GF Score™ of 73/100 and a GF Value™ of BDT761.21 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Pharma Aids's adjusted free cash flow per share for the three months ended in Mar. 2026 was BDT2.729. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is BDT8.82 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pharma Aids's average Cyclically Adjusted FCF Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Pharma Aids was -0.20% per year. The lowest was -0.20% per year. And the median was -0.20% per year.

As of today (2026-07-29), Pharma Aids's current stock price is BDT611.00. Pharma Aids's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was BDT8.82. Pharma Aids's Cyclically Adjusted Price-to-FCF of today is 69.27.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharma Aids was 124.75. The lowest was 55.34. And the median was 82.07.


Pharma Aids  (DHA:PHARMAID) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pharma Aids's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=611.00/8.82
=69.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharma Aids was 124.75. The lowest was 55.34. And the median was 82.07.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Pharma Aids Cyclically Adjusted FCF per Share Related Terms


Pharma Aids Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Pharma Aids's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Aids Cyclically Adjusted FCF per Share Chart

Pharma Aids Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 7.48 7.10 8.13 7.44

Pharma Aids Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.33 7.44 7.95 8.25 8.82

DHA:PHARMAID vs ISRG, BDX, MDLN: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Pharma Aids's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Aids Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pharma Aids's Cyclically Adjusted Price-to-FCF falls into.


DHA:PHARMAID
73GF Score
Pharma Aids Ltd DHA:PHARMAID
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Aids Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma Aids's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.729/330.2130*330.2130
=2.729

Current CPI (Mar. 2026) = 330.2130.

Pharma Aids Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 6.000 241.018 8.220
201609 -0.702 241.428 -0.960
201612 -0.328 241.432 -0.449
201703 -1.871 243.801 -2.534
201706 6.992 244.955 9.426
201709 1.870 246.819 2.502
201712 1.460 246.524 1.956
201803 -1.368 249.554 -1.810
201806 10.527 251.989 13.795
201809 5.927 252.439 7.753
201812 4.613 251.233 6.063
201903 -3.226 254.202 -4.191
201906 0.149 256.143 0.192
201909 4.821 256.759 6.200
201912 7.363 256.974 9.461
202003 -1.845 258.115 -2.360
202006 1.100 257.797 1.409
202009 1.817 260.280 2.305
202012 9.182 260.474 11.640
202103 -4.324 264.877 -5.391
202106 -0.004 271.696 -0.005
202109 3.370 274.310 4.057
202112 11.172 278.802 13.232
202203 0.830 287.504 0.953
202206 -4.524 296.311 -5.042
202209 0.076 296.808 0.085
202212 2.795 296.797 3.110
202303 2.585 301.836 2.828
202306 -3.834 305.109 -4.149
202309 3.263 307.789 3.501
202312 6.886 306.746 7.413
202403 2.631 312.332 2.782
202406 -5.536 314.175 -5.819
202409 -0.199 315.301 -0.208
202412 -0.003 315.605 -0.003
202503 0.368 319.799 0.380
202506 -10.071 322.561 -10.310
202509 8.111 324.800 8.246
202512 1.205 324.054 1.228
202603 2.729 330.213 2.729

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of BDT8.82 mean?
Pharma Aids (DHA:PHARMAID) has a Cyclically Adjusted FCF per Share of BDT8.82 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pharma Aids and its competitors.
Is Pharma Aids' Cyclically Adjusted FCF per Share too high?
Pharma Aids' current Cyclically Adjusted FCF per Share is BDT8.82. Overall, Pharma Aids has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Aids' Cyclically Adjusted FCF per Share compare to ISRG and BDX?
Pharma Aids' Cyclically Adjusted FCF per Share of BDT8.82 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pharma Aids and its competitors. Pharma Aids's current Cyclically Adjusted FCF per Share is BDT8.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Aids stock overvalued right now?
Based on GuruFocus' analysis, Pharma Aids (DHA:PHARMAID) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT761.21, compared to a current price of BDT611.00 — trading 19.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is BDT8.82. Pharma Aids' overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Pharma Aids (DHA:PHARMAID), the current Cyclically Adjusted FCF per Share is BDT8.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Aids (DHA:PHARMAID) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Aids stock appears to be undervalued. The current stock price of BDT611.00 is trading 19.7% below its estimated GF Value™ of BDT761.21. GuruFocus considers Pharma Aids to be Modestly Undervalued.

Key valuation signals for DHA:PHARMAID:

  • Cyclically Adjusted FCF per Share: BDT8.82
  • GF Value™: BDT761.21 vs. price of BDT611.00 (19.7% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the DHA:PHARMAID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Aids Business Description

Address 345 Segun Bagicha, 1st Floor, Ramna, Dhaka, BGD, 1000
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).
73GF Score

Get the complete analysis for DHA:PHARMAID

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT611.00
Price
BDT761.21
GF Value